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Abstract 
Aims: Ventilation at altitude changes due to altered levels of pO2, pCO2 and the effect 
on blood pH. Nocturnal ventilation is particularly exposed to these changes. We 
hypothesized that increasing neural respiratory drive is associated with the severity of 
sleep-disordered breathing at altitude.  
Methods: Mountaineers were studied at sea level (London, UK), and at altitude at the 
Aconcagua (Andes, Argentina). Neural respiratory drive (NRD) was measured as 
electromyogram of the diaphragm (EMGdi) overnight by a transoesophageal multi-
electrode catheter and results reported for sea level, 3,380m, 4,370m and 5,570m.  
Results: Four healthy subjects (3 male, age 31(3)years, body-mass-index 
23.6(0.9)kg/m2, neck circumference 37.0(2.7)cm, FEV1 111.8(5.1)%predicted, FVC 
115.5(6.3)%predicted) were studied. No subject had significant sleep abnormalities at 
sea level. Time to ascent to 3,380m was one day, to 4,370m five days, and the total 
nights at altitude was 21 days. The oxygen desaturation index (4%ODI 0.8(0.4), 22.0 
(7.2), 61.4 (26.9), 144.9/hour, respectively) and the EMGdi (5.2 (1.9), 12.8 (5.1), 14.1 
(3.4), 18.5%, respectively) increased with the development of periodic breathing at 
altitude, while the average SpO2 declined (97.5 (1.3), 84.8 (0.5), 81.0 (4.1), 68.5%, 
respectively). The average EMGdi correlated well with the 4%ODI (r=0.968, 
p=0.032).  
Conclusion: Neural respiratory drive during sleep increases at altitude in relation to 
the severity of periodic breathing. 
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Introduction 
 
Respiratory control at altitude differs from that at sea level in the awake (Khoo et al. 
1982) and asleep normal subjects (Bloch et al. 2010). While awake, it enables people 
at altitude to vary their respiratory pattern and maintain oxygen saturation (Hermand 
et al. 2015). At sea level breathing becomes more shallow with sleep onset and, at 
altitude, this decrease in ventilation leads to increased levels of hypoxia (Colrain et al. 
1987). In response to the developing hypoxia a compensatory hyperventilation results 
in hypocapnia and respiratory alkalosis, and with low levels of carbon dioxide (pCO2) 
the apnoea threshold is reached (Xie et al. 2001). As a consequence of the time delay 
in response to the apnoea the carbon dioxide levels rise and the oxygen levels drop, 
which explains the periodic occurrence of hyperventilation and apnoeas, described as 
Cheyne-Stokes-Ventilation (Harrison et al. 1934). 
 
Neural respiratory drive (NRD), as measured by the electromyography of the 
diaphragm (EMGdi), is closely correlated with breathlessness (Reilly et al. 2011, 
Jolley et al. 2015, Jolley and Moxham 2016) and can be recorded breath-by-breath 
while patients are asleep (Steier et al. 2010, Xiao et al. 2014). 
 
We hypothesized that sleep-disordered breathing at altitude is closely correlated with 
NRD, and that high levels of NRD would lead to increasing numbers of apnoeas and a 
greater severity of sleep disordered breathing with ascent to high altitude. 
 
Participants and Methods 
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This study was planned as part of a programme to assess “Neural Respiratory Drive in 
cardiopulmonary conditions and normal subjects”, it was approved by the local 
research ethics’ committee at King’s College London, UK (Reference number: 
05/Q0703/82; V3-21/02/2006). Informed written consent was obtained prior to 
inclusion by all participants. 
 
An expedition to the Aconcagua, Argentina (peak altitude 6,962m) was planned to 
assess NRD in asleep healthy volunteers. For this purpose four mountaineers were 
recruited and initially studied in the sleep laboratory at sea level (King’s College 
Hospital, London, UK). Exclusion criteria were any medical conditions that could put 
participation during a mountaineering expedition at altitude at risk; only young 
healthy subjects were recruited. We recorded demographics, spirometry, full 
polysomnography, tests of respiratory muscle strength and baseline recordings of the 
EMG of the diaphragm and the parasternal intercostal muscles. The equipment was 
taken for a test to the International Foundation High Altitude Research Station 
Jungfraujoch, CH (November 2007; altitude 3,450m). The expedition to the 
Aconcagua started in December 2007 and finished at the end of January 2008 
ascending via Confluencia (3,380m), Plaza de Mulas (4,370m), Camp Canada 
(5,050m), Camp Alaska (5,200m), and Nido de Condores (5,570m), but overnight 
sleep studies were performed at 3,380m, 4,370m and 5,570m only. For reasons of 
safety, a stop of at least two days at each level of altitude was planned. All 
mountaineers passed a medical examination prior to commencing the climb and again 
at Plaza de Mulas (4,370m), none showed any of the following signs or symptoms of 
altitude sickness or pulmonary oedema: 
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Symptoms: 
• Difficulty in breathing at rest 
• Cough 
• Weakness or decreased exercise performance 
• Chest tightness or congestion 
 
Signs: 
• Crackles or wheezing in at least one lung field 
• Central cyanosis 
• Tachypnoea 
• Tachycardia 
 
The recording equipment stopped working after the 1st night at Nido de Condores 
(5,570m), only one sleep study (subject JS) could be obtained. 
 
Demographics 
At baseline, age (years), gender (male/female), height (m) and weight (kg) were 
recorded, and body mass index (BMI) was calculated (kg/m2). To assess the risk of 
sleep-disordered breathing, neck circumference (cm) was measured using a standard 
tape measure.  
 
Spirometry 
Baseline spirometry was recorded following calibration of the equipment using a 3L 
syringe (Vitalograph®, Buckingham, England), seated with a noseclip on and using a 
tube mouthpiece. The recording spirometer was a Vitalograph Gold Standard 
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(Vitalograph®, Buckingham, England). The participants were asked to breathe in 
slowly to total lung capacity (TLC) and then to blow out as fast and hard as they 
could to measure the forced expiratory volume in one second (FEV1) and the forced 
vital capacity (FVC). The manoeuvres were repeated at least five times, until 
consistent results were obtained according to ATS/ERS criteria for the standardization 
of spirometry {Miller, 2005 #833}. 
 
Respiratory muscle tests 
Tests of inspiratory and expiratory muscle strength were performed following 
baseline spirometry. The participants were seated and for the mouth pressure 
measurements a flanged mouthpiece was used, with a noseclip on; for the sniff 
pressure measurement a sniff plug was inserted into one nostril (Heritier et al. 1994). 
The maximum inspiratory mouth and the sniff nasal pressures were recorded from 
functional residual capacity (FRC) while the maximum expiratory mouth pressure 
was recorded from TLC. A handheld portable pressure meter (MicroRPM® 
Respiratory Muscle Testing, Carefusion®, Basingstoke, UK) was used to record the 
pressures. 
 
Polysomnography 
A full polysomnography was performed using Alice5® equipment 
(Respironics®,Murrysville, PA, USA) at sea level. Electrical activity of the brain 
(EEG) was measured with surface electrodes (Gold), according to the ten-twenty 
system we recorded F4/M1, C4/M1 and O2/M1. Sleep and respiratory events were 
scored with standard terminology (Iber et al. 2007). Electro-oculography (EOG) was 
measured by Gold surface electrodes to detect rapid eye movements (REM). A 
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position electrode measured on which side the patient was lying. Pulse oximetry 
sensed the oxygen saturation and heart rate. Airflow was detected via a nasal cannula 
(sensing pressure) and an oronasal thermistor. Abdominal and chest wall movements 
were detected via uncalibrated inductance plethysmography bands around the chest 
and abdomen. Apnoeas were defined as no airflow for >10s, hypopnoeas were 
defined as periods of reduced airflow <50% from baseline for >10s. Obstructive 
episodes were scored if there was ongoing inspiratory effort measured during apnoeas 
or hypopnoeas; the events were scored as central if ventilatory effort was absent. 
Respiratory effort related arousals were scored if an arousal occurred following a 
period of >10s with increased inspiratory effort which did not meet the criteria of 
apnoea or hypopnoea. 
 
Pulse oximetry 
During ascent to altitude, pulse oximetry (Nonin Medical Inc®, Plymouth, MN/USA) 
recorded an average of 30.5 (4.3) hours for the subjects. Each mountaineer had an 
overnight pulse oximetry combined with EMG recordings at 3,380m and at 4,370m, 
recording was only possible in one mountaineer at 5,570m. The data were analysed 
upon return to London and average oxygenation (SpO2), nadir and the 4% oxygen 
desaturation index (ODI) were calculated. 
 
Electromyography 
A multipair electrode catheter (Yinghui Medical Tech Ltd®, Guangzhou, China) was 
inserted via one nostril to record the transoesophageal EMGdi, as previously 
described (Luo et al. 2008, Steier et al. 2010), connected to RA-8® amplifiers 
(Yinghui Medical Tech Ltd®, Guangzhou, China) that further transmitted the signal to 
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an analog-to-digital converter, Powerlab® 16/30 running Chart® Version 5 
(ADInstruments®, Colorado Springs/CO, USA).  
 
The EMG of the neck muscles, parasternal intercostals, and abdominal muscles was 
recorded using surface electrodes (Kendall Arbo®, Tyco Healthcare®, Neustadt, 
Germany) from standard positions (White et al. 1995, Maarsingh et al. 2000, Konrad 
et al. 2001, Duivermann et al. 2004, Lasserson et al. 2006). The surface electrodes 
were positioned on the sternocleidomastoid (neck) muscle bilaterally 2cm above the 
clavicle and 3cm beneath the mastoid process (EMGneck). A reference electrode was 
placed on the skin 6cm lateral to the midline below the clavicles. For recording the 
EMG of the parasternal intercostals (EMGpara) electrodes were placed on each side 
of the sternum 3cm from the midline in the second intercostal space (Reilly et al. 
2011). The EMG of the abdominal muscles (EMGabdomen) was recorded from 
electrodes 2-3cm lateral to the umbilicus bilaterally over the region of the rectus 
abdominis. 
 
The EMG was recorded during resting breathing and during the manoeuvres that have 
been described to achieve maximum or close to maximum activation of the 
diaphragm; whilst breathing in to total lung capacity (TLC manoeuvre), whilst 
breathing in as hard as possible against a closed airway (PImax manoeuvre), maximal 
sniffs, and maximum voluntary ventilation for 15s (“sprint MVV”)). Additionally, 
EMG was recorded during maximal expiration against an occluded valve (PEmax 
manoeuvre). Manoeuvres were repeated until consistent results were achieved, at least 
five times, and the maximum of all manoeuvres was then selected to represent 100% 
activity. The recordings of the spontaneous EMG were sampled at 1kHz, and EMG 
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data were filtered with a high-pass 30 Hz and an additional low pass 1kHz filter. The 
rectified signals of the EMG (root-mean-square of the raw data) were quantified and 
transformed into percent of maximum activity (as derived from the maximum 
inspiratory and expiratory manoeuvres described above).  
 
The equipment was powered by two Victron Energy AMG GEL 12-35 batteries (120 
Ah; Victron Energy, Nuneaton, UK) that were connected to a Phoenix Inverter 12/350 
/ Blue Power Charger 45-65Hz, 200W 12V/15A (Victron Energy, Nuneaton, UK), 
and charged by six standard flexible outdoor solar panels (560 x 1490 mm, 
12V/140W). 
 
All EMG channels (diaphragm, neck, parasternal, abdomen) were recorded at sea 
level. At altitude, the EMG of the diaphragm (transoesophageal), the parasternal 
intercostals and the abdominal muscles (surface EMG) were recorded and analysed. 
The placement of the transoesophageal multipair electrode catheter allows the 
recording of five channels around the electrically active region of diaphragm. The 
positioning of the oesophagel catheter is such that channel 1 and channel 5 provide 
the largest recorded signal which are then selected for analysis (root mean square, 
time constant 100ms of the peak signal), as previously described.8-10 The ‘absolute 
level of NRD’ is defined as the recorded percentage of maximum activity allowing 
the comparison of levels of drive between different subjects and different conditions, 
as described by our group 6,9,11-13 and others.14 To obtain an average of the NRD, each 
non-periodic breath during a one-minute period at the end of each ten-minute period 
at night was analysed and included, if variability of the signal was less than 25% from 
baseline. These one-minute data blocks were summed and the mean of the sum of 
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these values taken for the whole night to calculate the average level of NRD 
(baseline). 
The occurrence of cyclical changes in a biosignal, e.g. during periodic breathing but 
also commonly observed during obstructive sleep apnoea, makes analysis difficult. It 
requires the description of an average baseline and of the deviation from that baseline. 
In respiratory sleep medicine this is achieved by reporting the average nocturnal SpO2 
plus the number of desaturation events (oxygen desaturation index, ODI). In the 
analysis of the EMG signals, a similar approach was achieved by providing the 
average EMG between apnoeas to provide the baseline plus the slopes of the EMG 
signal (decrescendo, crescendo) prior to and following central apnoeic events, as 
previously described in other forms of sleep-disordered breathing,9,12,13 as well as the 
index of respiratory events. 
 
Outcome parameters 
In order to define the correlation between NRD and sleep-disordered breathing the 
level of neural respiratory drive, as measured by the EMGdi (%max), was recorded at 
each level of altitude and differential respiratory muscle recruitment, as expressed by 
the EMG activity of different muscle groups, was further correlated to abnormal 
breathing patterns. Other outcomes were the apnoea threshold of NRD and the 
EMGdi that was associated with central sleep apnoeas, as well as the oxygen 
desaturation index (4%ODI), the mean and nadir nocturnal SpO2, and the surface 
EMG of the parasternal intercostal and abdominal muscles. Sleep studies with 
recording of the EMG and nocturnal pulse oximetries were performed the first night 
when ascending to a new altitude.  Time to ascent to 3,380m was one day, to 4,370m 
five days, and to 5,570m thirteen days; the total of nights spent at altitude was 21 
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days. 
 
Statistical analysis 
SPSS® Version 20.0 (SPSS® Inc, Chicago, IL/USA) was used for the analysis. Results 
are reported as mean (standard deviation, SD) for all normally distributed test results, 
results represent the average data of the first night at a new altitude. The small sample 
size of the group with multiple comparisons at different altitudes precluded the use of 
a many statistical tests and, instead, we decided to report the 95% Confidence Interval 
(95%CI) to provide information about overlap of the group’s means. Significance was 
accepted with a p-value <0.05. 
 
Results 
Four healthy mountaineers were studied at sea level and during ascent to altitude. The 
group was young, predominantly male, normal in weight and without any obvious 
respiratory abnormalities (Table 1). 
 
The global inspiratory, diaphragm and expiratory muscle strength was normal. 
Respiratory muscle EMG recordings revealed diaphragm and parasternal activity 
while awake similar to that observed in normal subjects (Steier et al. 2010), as well as 
low neck muscle and expiratory muscle activity (Table 2). 
 
The polysomnography at sea level, revealed a short sleep time with preserved sleep 
architecture and a relatively normal sleep efficiency. There were no respiratory 
abnormalities, no significant apneas or hypopnoeas were observed, and there was no 
hypoventilation (Table 3). 
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Sleep-disordered breathing developed with increasing altitude in all subjects and the 
severity increased with higher altitude, leaving all subjects with severe central sleep 
apnoea and periodic breathing (Table 4). Recordings at 5,570m were obtained only in 
one subject who had a 4%ODI of 144.9 x h-1, mean SpO2 of 68.5% and a nadir SpO2 
of 50.4%. 
 
The EMG recordings at different altitudes showed increased variability that was 
associated with the development of sleep-disordered breathing. Cyclical crescendo-
decrescendo patterns of inspiratory EMG activity were observed during most of the 
night (Figure 1).  
 
Following sleep onset, EMG activity decreased significantly at sea level. At 3,380m 
increased EMG activity of the diaphragm, the parasternal intercostals and the 
abdominal muscles was observed throughout the night. This activity did not increase 
significantly with further ascent to an altitude of 4,370m (Table 4). 
 
There was a positive correlation between the 4%ODI at 4,370m and the EMGdi at 
3,380m (r=0.97, p=0.03) as well as a negative correlation with the EMGparasternal at 
sea level (r=-0.96, p=0.04) and at 4,370m (r=-0.97, p=0.03). There was also an 
inverse relationship between the EMGdi at 3,380m and the EMGparasternal at 
4,370m (r=-0.99, p<0.01). 
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The cyclical occurrence of highly variable inspiratory activity when breathing asleep 
at altitude made it difficult to analyse stable periods of EMG activity and calculate 
averages (Figure 2). 
 
Discussion 
Neural respiratory drive, as measured by the diaphragm EMG, increases with high 
altitude as a response to hypobaric environmental conditions. The increased levels of 
drive are directly associated with the development of sleep disordered breathing. The 
apnoea threshold during periodic breathing is reached when EMGdi activity falls to 
levels below 5% maximum, the level required for resting breathing at sea level, and 
breathing resumes again when approximately 10% of maximum EMGdi activity is 
reached following central apnoea. To support diaphragm activity, extra-diaphragmatic 
muscles are recruited when asleep at altitude to achieve sufficient ventilation.  
 
Clinical significance 
In response to hypobaric conditions, a high neural respiratory drive at altitude 
increases ventilation to maintain oxygenation; this leads to intermittent hypocapnia 
with a respiratory alkalosis resulting in a Cheyne-Stokes respiration, particularly 
when asleep. The central apnoea threshold while asleep is reached when neural 
respiratory drive declines to a level lower than that required for resting breathing at 
sea level.  
 
It has been established that human beings develop sleep-disordered breathing at 
altitude, but the accurate measurement of physiological parameters has been 
challenging. This is the first study at high altitude that has recorded the 
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transoesophageal crural diaphragm EMG from the electrical active region which 
allows the accurate measurement of central motor neuron output (Neural Respiratory 
Drive) in humans (Luo, Tang et al. 2009, Jolley and Moxham 2016). Knowledge 
about how subjects recruit respiratory muscle activity during sleep helps to 
understand the factors that determine acclimatisation to high altitude. The levels of 
EMGdi activity at altitude, expressed as percent of maximum, are similar to that in 
patients with moderate COPD, asthma, obesity hypoventilation syndrome and 
obstructive sleep apnoea (Luo et al. 2008, Jolley et al. 2009, Steier et al. 2009, Steier 
et al. 2010, Steier et al. 2011). Thus respiratory reserve is reduced with increasing 
altitude and, despite increased muscle recruitment, both hypoxaemia when awake and 
sleep disordered breathing deteriorate with ascent to altitude. Interestingly, a level of 
neural respiratory drive similar to that at sea level predicts the imminent onset of 
central apnoea, the so called apnoea threshold (Xie et al. 2001, Steier et al. 2010). 
During this five-week long expedition, the limited acclimatisation at each level of 
altitude did not significantly affect the apnoea threshold. 
 
A high neural respiratory drive at altitude leads to a higher minute ventilation which 
results in more significant hypocapnia; this triggers apnoeas and oxygen 
desaturations, as indicated by the positive correlation between the EMG of the 
diaphragm and the oxygen desaturation index. However, in subjects who adopted a 
different breathing pattern at altitude by recruiting more chest wall muscle activity the 
sleep disordered breathing seemed to be less severe, as indicated by a negative 
correlation between the parasternal EMG and the ODI. In addition, central efferent 
output can be divided between different muscle groups at the same time. In the 
studied cohort at altitude, we recorded from the diaphragm and the parasternal EMG 
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to identify inspiratory muscle activity. The negative correlation between parasternal 
and diaphragm EMG indicates that the subject’s respiratory pattern varied and, as 
parasternal activity was recruited, diaphragm EMG was diminished. Considering that 
the volume effect of parasternal intercostal muscle activity will be significantly lower 
than the contribution from increased diaphragm activity, it is likely that subjects with 
increased chest wall muscle activity will have experienced less significant hypocapnic 
epsiodes, resulting in less severe sleep disordered breathing. 
 
These observations reflect the chemosensitivity to low levels of pCO2 following a 
period of relative hyperventilation that is employed to control for hypoxaemia in 
hypobaric environmental conditions. During a central apnoeic event the pCO2 level 
rises slowly back to normal levels which normalizes the pH, and the pO2 then starts to 
fall again with a circulatory delay.  
 
Limitations 
This was an exploratory study in a small group of mountaineers, limited by the 
number of participants and the difficult logistics’, allowing for hypothesis generation. 
However, data presentation using the 95% confidence interval and the reliable 
occurance and analysis of periodic breathing at altitude with repeated measurements 
at different levels of altitude allow a “proof of concept” to validate the observations. 
The study was further limited by a lack of access to polysomnography equipment at 
altitude but, as the baseline study at sea level confirmed the absence of any sleep 
disordered breathing, the reporting of the oxygen desaturation index in parallel to the 
recording of electromyography provided valuable information to assess ventilation. 
The data recorded were from the first night at each level of altitude, therefore were 
 16 
only available for a single night in each subject at each level. Future studies could be 
designed to understand the effect of acclimatization by recording subsequent nights in 
the same subjects. 
 
Conclusion 
Increased neural respiratory drive was associated with more severe sleep disordered 
breathing. Future research should investigate in detail whether there is a protective 
level of NRD and a gender effect predicting the ventilatory response at altitude.  
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Table legends: 
Table 1: Demographics of participants (n=4). BMI, body mass, index; FEV1, forced 
expiratory volume in 1s; FVC, forced vital capacity. Except for the gender ratio data 
are presented as mean (standard deviation; 95%CI). 
Table 2: Respiratory muscle strength and activity while awake at sea level. PImax, 
maximum inspiratory mouthpressure; PEmax, maximum expiratory mouthpressure; 
Psniff, nasal, maximum inspiratory sniff nasal pressure; EMG, electromyography. 
Data are presented as mean (standard deviation; 95%CI). 
Table 3: Results of the polysomnography at sea level (London, UK; 0m). TST, total 
sleep time; REM, rapid eye movement sleep; SE, sleep efficiency; SpO2, oxygen 
saturation; RDI, respiratory disturbance index. Data are presented as mean (standard 
deviation; 95%CI). 
Table 4: Respiratory parameters and EMG activity during sleep (EMGdi=NRD, 
primary outcome), expressed as percent of maximum activity at sea level, for 
inspiratory and expiratory muscles at sealevel and different altitudes (Night 1); only 
one sleep study was obtained at 5,570m. ODI, oxygen desaturation index; SpO2, 
oxygen saturation. EMG, electromyography. Data are presented as mean (standard 
deviation; 95%CI).  
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Figure legends: 
Figure 1: Periodic breathing while asleep in a healthy subject (BW) at 4,370m 
altitude. The inspiratory activity of the diaphragm EMG (EMGdi, mV) is clearly 
visible between the ECG artefacts in Channel 1, airflow indicates a central apnoea in 
Channel 2 (L/s). The decline in inspiratory EMGdi activity prior to the development 
of the apnoea can be described by the gradient of the 1st slope (Δy1/Δx1), the incline 
in inspiratory EMGdi activity following the apnoea is characterized by the gradient of 
the 2nd slope (Δy2/Δx2). 
Figure 2: Transoesophageal electromyography of the diaphragm (Channel 1-5; 
EMGdi) and airflow during sleep at 4,370m of altitude. The EMGdi channel display 
ECG artefacts (QRS complex) as well as inspiratory EMG activity. Airflow is 
indicated by pressure changes (Channel 6). There is a clear crescendo-decrescendo 
pattern in the inspiratory EMGdi activity followed by absence of any inspiratory 
activity during central apnoea. 
 
 
 
 
 
